Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H28F2N2O4 |
InChIKeyRJGWWNVHLMPYEN-BUHFOSPRSA-N |
CAS Registry2375846-41-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | RS | 01 Nov 2019 |